Literature DB >> 12780998

An ounce of prevention is a ton of work: mass antibiotic prophylaxis for anthrax, New York City, 2001.

Susan Blank1, Linda C Moskin, Jane R Zucker.   

Abstract

Protocols for mass antibiotic prophylaxis against anthrax were under development in New York City beginning in early 1999. This groundwork allowed the city's Department of Health to rapidly respond in 2001 to six situations in which cases were identified or anthrax spores were found. The key aspects of planning and lessons learned from each of these mass prophylaxis operations are reviewed. Antibiotic distribution was facilitated by limiting medical histories to issues relevant to prescribing prophylactic antibiotic therapy, formatting medical records to facilitate rapid decision making, and separating each component activity into discrete work stations. Successful implementation of mass prophylaxis operations was characterized by clarity of mission and eligibility criteria, well-defined lines of authority and responsibilities, effective communication, collaboration among city agencies (including law enforcement), and coordination of staffing and supplies. This model can be adapted for future planning needs including possible attacks with other bioterrorism agents, such as smallpox.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12780998

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


  5 in total

1.  Effective antimicrobial regimens for use in humans for therapy of Bacillus anthracis infections and postexposure prophylaxis.

Authors:  Mark R Deziel; Henry Heine; Arnold Louie; Mark Kao; William R Byrne; Jennifer Basset; Lynda Miller; Karen Bush; Michael Kelly; G L Drusano
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

2.  Determination of antibiotic efficacy against Bacillus anthracis in a mouse aerosol challenge model.

Authors:  Henry S Heine; Jennifer Bassett; Lynda Miller; Justin M Hartings; Bruce E Ivins; M Louise Pitt; David Fritz; Sarah L Norris; W Russell Byrne
Journal:  Antimicrob Agents Chemother       Date:  2007-02-12       Impact factor: 5.191

3.  The view from the trenches: part 1-emergency medical response plans and the need for EPR screening.

Authors:  Robert M Gougelet; Michael E Rea; Roberto J Nicolalde; James A Geiling; Harold M Swartz
Journal:  Health Phys       Date:  2010-02       Impact factor: 1.316

4.  Is 60 days of ciprofloxacin administration necessary for postexposure prophylaxis for Bacillus anthracis?

Authors:  G L Drusano; Olanrewaju O Okusanya; Adedoyin Okusanya; Brian Van Scoy; D L Brown; Robert Kulawy; Fritz Sörgel; Henry S Heine; Arnold Louie
Journal:  Antimicrob Agents Chemother       Date:  2008-08-25       Impact factor: 5.191

5.  Patients' request for and emergency physicians' prescription of antimicrobial prophylaxis for anthrax during the 2001 bioterrorism-related outbreak.

Authors:  Nkuchia M M'ikanatha; Kathleen G Julian; Allen R Kunselman; Robert C Aber; James T Rankin; Ebbing Lautenbach
Journal:  BMC Public Health       Date:  2005-01-05       Impact factor: 3.295

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.